Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...said Mr Starr. Ms Mercado declined to comment. John Correia, senior vice-president of operations at UG2, the Boston-based cleaning group that hired her, said the company was funding her defence....
...Competitive field Ian Read, chief executive of Pfizer, admitted recently that he was concerned by “buoyant” valuations of biotech stocks....
...The court’s decision today in Starr International Company, Inc. v. the United States recognizes that AIG’s shareholders are not entitled to compensation for that decision, and that the Federal Reserve’s...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Alongside sportswoman and fashion designer, she also has her own interior design firm, V*Starr, and is launching a book, Come to Win, on “how sports can help you top your profession”, during the second week...
...., and the role of C.V. Starr & Co., Inc....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...STATEMENT FROM C.V. STARR ON BEHALF OF HANK GREENBERG Mr....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...The writer is chairman and chief executive officer of C.V. Starr....
...“He could see around corners,” says Edward Matthews, one of Mr Greenberg’s most senior lieutenants at AIG and then at C.V. Starr, his investment vehicle....
...The case, MedImmune v Genentech, is technical but of “very great importance to the entire business community …and to the university research community”, says Kenneth Starr, former Whitewater special prosecutor...
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...“This is a technical case but one of very great importance to the business community,” says Kenneth Starr, former Whitewater special prosecutor and a Supreme Court expert at the law firm Kirkland & Ellis...
...Mr Greenberg and Edward Matthews, president of C.V....
...Greenberg represented C.V. Starr & Co. High hopes Could it be third time lucky for King Win Laurel?...
...Greenberg represented C.V. Starr & Co. Playing to type Hollywood blockbusters are supposed to be escapist....
...Greenberg represented C.V. Starr & Co. Role reversal After years of serving as a top consultant to the world’s largest media groups, Michael Wolf is joining one....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition